Skip to main content

Advertisement

SpringerLink
Log in

Central and Peripheral Hypotensive Activity of Urapidil and its Ml and M2 Metabolites in the Cat

  • Short Communication
  • Poster Presentation
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Hall MD, Gozlan H, Emerit MB, Mestikawy SEL, Pichat L, et al. Differentiation of pre- and postsynaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents. Neurochemical Research 11: 891–912, 1986

    Article  PubMed  CAS  Google Scholar 

  • Hanft G, Gross G. Subclassification of cq-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. British Journal of Pharmacology 97: 691–700, 1989

    Article  PubMed  CAS  Google Scholar 

  • Kolassa N, Beller K-D, Sanders KH. Involvement of brain T-HT1a receptors in the hypotensive response to urapidil. American Journal of Cardiology 64: 70–100, 1989

    Article  Google Scholar 

  • Langtry HD, Mammen GJ, Sorkin EN. Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension. Drugs 38: 900–940,1989

    CAS  Google Scholar 

  • McPherson GA. Analysis of radioligand binding experiments. Journal of Pharmacological Methods 14: 213–228, 1985

    Article  PubMed  CAS  Google Scholar 

  • Minneman KP. α1-Adrenergic receptor subtypes, inositol phosphates, and source so cell Ca2+. Pharmacological Reviews 40: 87–119,1988

    PubMed  CAS  Google Scholar 

  • Pazos A, Hoyer D, Palacios JM. Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors. European Journal of Pharmacology 106: 531–538, 1984

    Article  PubMed  CAS  Google Scholar 

  • Sanders KH, Beller K-D, Eltze M, Kolassa N. Urapidil and some analogs with high affinities for serotonin-1A and α1-adrenoceptor binding sites show potent hypotensive activity upon central administration. Current Opinion in Cardiology 4 (Suppl. 4): S49–S55, 1989

    Google Scholar 

  • van Meel JCA, De Jonge A, Timmermans PBMWM, van Zwieten PA. Selectivity of some alpha-adrenoceptor agonists for peripheral alpha-1 and alpha-2 adrenoceptors in the normotensive rat. Journal of Pharmacology and Experimental Therapeutics 219: 760–767, 1981

    PubMed  Google Scholar 

  • van Zwieten PA. Antihypertensive drugs with a central action. Progress in Pharmacology 1: 1–63, 1975

    Google Scholar 

  • van Zwieten PA, Mathy MJ, Thoolen MJMC. Deviating central hypotensive activity of urapidil in the cat. Journal of Pharmacy and Pharmacology 37: 810–811, 1985

    Article  PubMed  Google Scholar 

  • Volpe M, Trimarco B, Rosiello G, Mele AF, Cuocolo A, et al. Antihypertensive effect of urapidil: a randomized, double-blind study in mild or moderate hypertensive patients. In Amery (Ed.) Treatment of hypertension with urapidil, pp. 135–143, Royal Society of Medicine Services, London, 1986

    Google Scholar 

  • Zech K, Eltze M, Kilian U, Sanders KH, Kolassa N. Biotransformation of urapidil: metabolites in serum and urine and their biological activity in vitro and in vivo. Archives Internationales de Pharmacodynamie et de Thérapie 272: 180–196, 1984

    PubMed  CAS  Google Scholar 

  • Zech K, Steinijans VW, Radtke HW. Pharmacokinetics of urapidil in normal subjects. In Amery A (Ed.) Treatment of hypertension with urapidil, pp. 29–38, Royal Society of Medicine Services, London, 1986

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Byk Gulden Pharmaceuticals, POB 6500, D-7750, Konstanz, Federal Republic of Germany

    H. Boss, K. -D. Beller & K. H. Sanders

  2. Department of Biochemistry, Byk Gulden Pharmaceuticals, Konstanz, Federal Republic of Germany

    R. Boer

Authors
  1. H. Boss
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Boer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. -D. Beller
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. H. Sanders
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Boss, H., Boer, R., Beller, K.D. et al. Central and Peripheral Hypotensive Activity of Urapidil and its Ml and M2 Metabolites in the Cat. Drugs 40 (Suppl 4), 34–37 (1990). https://doi.org/10.2165/00003495-199000404-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199000404-00009

Keywords

Search

Navigation